Historical record - last NADAC effective date: 6/17/2015
Product Information
EPIVIR 150 MG TABLET is a brand product labeled by ViiV Healthcare Company, priced at $6.6144 per EA under NDC 49702020318. Its NADAC has been published 109 times since Jan 22, 2014.
FDA first approved this application on Nov 17, 1995. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the lamivudine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
150 mg/1
Manufacturer
ViiV Healthcare CompanyNDC
49702020318
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
6/17/2015
Active Ingredients
LAMIVUDINEApproval Type
New Drug (NDA)
FDA Application
NDA020564FDA Approved
11/17/1995
TE Code
AB
On Market Since
10/4/2010
Pharmacological Classes
Price Statistics
The NADAC for EPIVIR 150 MG TABLET has been published 109 times since Jan 22, 2014, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.6144 per EA |
|---|---|
| All-time high | $6.7066 (Feb 11, 2015) |
| All-time low | $6.6144 (Jun 17, 2015) |
| Median price | $6.7066 |
| Average price | $6.6618 |
| Largest weekly change | -1.4% (Jun 17, 2015) |
| Weeks tracked | 109 |
| Tracking since | Jan 22, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-1.4%
Last surveyed Jun 15, 2016 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 93% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
ViiV Healthcare Company manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
lamivudine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of EPIVIR 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for EPIVIR 150 MG TABLET, manufactured by ViiV Healthcare Company, is $6.6144 per EA (NDC 49702020318), effective Jun 15, 2016.
How has the price of EPIVIR 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for EPIVIR 150 MG TABLET has held within roughly two percent of its current level. It has been tracked across 109 weekly CMS publications since Jan 22, 2014.
What are the highest and lowest recorded NADAC prices for EPIVIR 150 MG TABLET?
Since Jan 22, 2014, the NADAC for EPIVIR 150 MG TABLET has ranged from a low of $6.6144 (Jun 17, 2015) to a high of $6.7066 (Feb 11, 2015), with a median of $6.7066 per EA.
Are there cheaper alternatives to EPIVIR 150 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LAMIVUDINE 150 MG TABLET, is $0.4887 per EA — about 93% below EPIVIR 150 MG TABLET.
Who manufactures EPIVIR 150 MG TABLET?
EPIVIR 150 MG TABLET (NDC 49702020318) is labeled by ViiV Healthcare Company, and CMS classifies it as a brand product.